Go Pro
→ How options let you do more with less capital (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$109.86
+2.7%		$102.94
$61.22
▼
$116.85
$12.47B0.881.93 million shs2.60 million shs
Mexco Energy Co. stock logo
MXC
Mexco Energy
$10.06
+0.9%		$9.99
$7.16
▼
$16.48
$20.58M0.3530,155 shs92,886 shs
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
$7.73
+1.6%		$5.80
$2.56
▼
$8.30
$79.15M-0.5470,939 shs125,642 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
-3.13%-7.19%-0.72%+34.60%+42.70%
Mexco Energy Co. stock logo
MXC
Mexco Energy
+1.32%-7.51%+5.95%+25.73%+12.96%
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
+6.14%+15.13%+22.15%+81.19%+164.24%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$109.86
+2.7%		$102.94
$61.22
▼
$116.85
$12.47B0.881.93 million shs2.60 million shs
Mexco Energy Co. stock logo
MXC
Mexco Energy
$10.06
+0.9%		$9.99
$7.16
▼
$16.48
$20.58M0.3530,155 shs92,886 shs
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
$7.73
+1.6%		$5.80
$2.56
▼
$8.30
$79.15M-0.5470,939 shs125,642 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
-3.13%-7.19%-0.72%+34.60%+42.70%
Mexco Energy Co. stock logo
MXC
Mexco Energy
+1.32%-7.51%+5.95%+25.73%+12.96%
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
+6.14%+15.13%+22.15%+81.19%+164.24%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
2.62
Moderate Buy$91.20-16.99% Downside
Mexco Energy Co. stock logo
MXC
Mexco Energy
0.00
N/AN/AN/A
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
2.50
Moderate BuyN/AN/A

Current Analyst Ratings Breakdown

Latest N4P, PXS, MXC, and HALO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/29/2026
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
Alliance Global Partners logo
Alliance Global Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
9/28/2026
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C+) ➝ Hold (C)
9/14/2026
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C+)
9/2/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$115.00
9/1/2026
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
8/31/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeBuy (B-) ➝ Buy (B)
8/14/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy (B) ➝ Buy (B-)
8/7/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform
8/7/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$96.00 ➝ $105.00
8/7/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Citizens Jmp logo
Citizens Jmp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetMarket Outperform$92.00 ➝ $93.00
8/7/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$75.00 ➝ $95.00
(Data available from 10/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$1.40B8.93$4.75 per share23.14$0.42 per share261.57
Mexco Energy Co. stock logo
MXC
Mexco Energy
$6.79M3.03$1.39 per share7.25$8.81 per share1.14
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
$42.35M1.87$1.09 per share7.06$9.67 per share0.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$316.89M$3.3532.7911.770.4224.86%260.98%23.91%11/2/2026 (Estimated)
Mexco Energy Co. stock logo
MXC
Mexco Energy
$1.35M$0.7515.97N/AN/A18.73%7.57%6.94%N/A
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
$1.99M$0.819.54N/AN/A20.00%8.24%4.42%11/19/2026 (Estimated)

Latest N4P, PXS, MXC, and HALO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/31/2026Q2 2026
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
$0.20$0.27+$0.07$0.27$10.34 million$12.13 million
8/6/2026Q2 2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$1.79$2.28+$0.49$1.90$402.28 million$481.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
N/AN/AN/AN/AN/A
Mexco Energy Co. stock logo
MXC
Mexco Energy
$0.100.99%N/A13.33%N/A
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
13.50
2.71
2.31
Mexco Energy Co. stock logo
MXC
Mexco Energy
N/A
3.53
3.53
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
0.70
4.72
4.68

Institutional Ownership

CompanyInstitutional Ownership
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
97.79%
Mexco Energy Co. stock logo
MXC
Mexco Energy
5.89%
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
56.19%

Insider Ownership

CompanyInsider Ownership
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
2.50%
Mexco Energy Co. stock logo
MXC
Mexco Energy
55.53%
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
54.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
423113.50 million110.66 millionOptionable
Mexco Energy Co. stock logo
MXC
Mexco Energy
42.05 million961,000Not Optionable
Pyxis Tankers Inc. stock logo
PXS
Pyxis Tankers
410.24 million4.65 millionNot Optionable

Recent News About These Companies

Pyxis Tankers consensus price target raised 15.00% to $11.73
October 2 at 12:33 PM  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/pyxis-tankers-consensus-price-target-raised-15-00-to-11-73/ar-AA2dpCOH
Pyxis Tankers Inc. (NASDAQ:PXS) Shares Shorted: Short Interest Up 72.8% in September
September 30 at 5:19 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/options-pyxis-tankers-inc-nasdaq-pxs-shares-shorted-short-interest-up-728-in-september-2026-09-30/
Alto Ingredients (NASDAQ:ALTO) versus Pyxis Tankers (NASDAQ:PXS) Critical Analysis
September 28, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31057375
Pyxis Tankers Inc.
September 18, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/pxs/research-ratings?gaa_n=AWEtsqfoJBktdfwKzZQhTC0v-sFCPkP-1rt8TvIQWEP3tN3gXGYxEaspsaTe&gaa_ts=698ea11a
Pyxis Tankers Sets August 31 Release for Second-Quarter 2026 Results
September 4, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/pyxis-tankers-sets-august-31-release-for-second-quarter-2026-results?utm_source=marketbeat.com&utm_medium=referral
Pyxis boss keeps lock on $100m war chest as ship prices surge
September 1, 2026  |  tradewindsnews.comT
Why Pyxis Tankers Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
September 1, 2026  |  benzinga.comhttps://www.benzinga.com/trading-ideas/movers/26/09/61540507/why-pyxis-tankers-shares-are-trading-higher-by-over-11-here-are-20-stocks-moving-premarket?utm_source=snapi
Pyxis Tankers (Βαλέντιος Βαλεντής): Κέρδη 6,5 εκατ. δολάρια και ρευστότητα 103 εκατ. δολαρίων
September 1, 2026  |  mononews.grM
Pyxis Tankers Inc. publie ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2026
September 1, 2026  |  zonebourse.comZ
Pyxis Tankers (PXS) Stock Rises on Q2 2026 Earnings
August 31, 2026  |  quiverquant.comQ
Pyxis Tankers Announces Financial Results for the Three & Six Months Ended June 30, 2026
August 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/31/3353699/0/en/pyxis-tankers-announces-financial-results-for-the-three-six-months-ended-june-30-2026.html
Pyxis Tankers Inc. Announces Date for Second Quarter 2026 Financial Results Release
August 26, 2026  |  quiverquant.comQ
Pyxis Tankers Announces Date for the Release of the Second Quarter 2026 Results
August 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/26/3351690/0/en/pyxis-tankers-announces-date-for-the-release-of-the-second-quarter-2026-results.html
Why Could Pyxis Tankers (NASDAQ:PXS) Earnings Matter for Oil Stocks?
August 17, 2026  |  kalkinemedia.comK
Pyxis Tankers (NASDAQ:PXS): What Does Today’s Tanker Operations Put In Focus?
August 17, 2026  |  kalkinemedia.comK
Pyxis Tankers Announces M/T “Pyxis Karteria” Safely Exits the Strait of Hormuz
June 24, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/pyxis-tankers-announces-m-t-pyxis-karteria-safely-exits-the-strait-of-hormuz-1036271864
Crude Oil Slips Below $90—Yet These 4 Tanker Stocks Reach Top-Tier Momentum Zones
June 12, 2026  |  benzinga.comhttps://www.benzinga.com/markets/equities/26/06/53160325/crude-oil-slips-below-90-yet-these-4-tanker-stocks-reach-top-tier-momentum-zones?utm_source=snapi
A new cargo ship just crossed the Atlantic with towering wing-sails doing most of the work — slashing fuel burn 40% and pointing the way past bunker-oil engines
May 30, 2026  |  msn.comhttps://www.msn.com/en-us/news/technology/a-new-cargo-ship-just-crossed-the-atlantic-with-towering-wing-sails-doing-most-of-the-work-slashing-fuel-burn-40-and-pointing-the-way-past-bunker-oil-engines/ar-AA24ieIn
Pyxis Tankers releases first quarter 2026 financial results
May 20, 2026  |  drybulkmagazine.comD
Pyxis Tankers Inc.: Pyxis Tankers Announces Financial Results for the Three Months Ended March 31, 2026
May 19, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-05/68532249-pyxis-tankers-inc-pyxis-tankers-announces-financial-results-for-the-three-months-ended-march-31-2026-399.htm
Pyxis Tankers eyes lucrative charter renewals and scours secondhand market
May 19, 2026  |  tradewindsnews.comT

New MarketBeat Followers Over Time

Media Sentiment Over Time

Halozyme Therapeutics stock logo

Halozyme Therapeutics NASDAQ:HALO

$109.86 +2.92 (+2.73%)
Closing price 04:00 PM Eastern
Extended Trading
$109.86 +0.00 (+0.00%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; rilpivirine, cabotegravir, and N6LS BNAB for the treatment of HIV; ocrelizumab for multiple sclerosis; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of chronic lymphocytic leukemia; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergic reactions; nivolumab+relatlimab and ANTI-TIM3 for the treatment of solid tumors; ARGX-117 for multifocal motor neuropathy; atezolizumab; nivolumab; afgartigimod; teriparatide injections; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.

Mexco Energy stock logo

Mexco Energy NYSE:MXC

$10.06 +0.09 (+0.90%)
Closing price 04:00 PM Eastern
Extended Trading
$10.10 +0.04 (+0.35%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Mexco Energy Corporation, an independent oil and gas company, engages in the acquisition, exploration, development, and production of natural gas, crude oil, condensate, and natural gas liquids in the United States. It owns partial interests in approximately 6,400 gross producing wells located in the states of Texas, New Mexico, Oklahoma, Louisiana, Alabama, Mississippi, Arkansas, Wyoming, Kansas, Colorado, Montana, Virginia, North Dakota, and Ohio. It also owned leasehold mineral, royalty, and other interests in approximately 2,768 net acres. The company was formerly known as Miller Oil Company and changed its name to Mexco Energy Corporation in April 1980. Mexco Energy Corporation was incorporated in 1972 and is based in Midland, Texas.

Pyxis Tankers stock logo

Pyxis Tankers NASDAQ:PXS

$7.73 +0.12 (+1.58%)
Closing price 04:00 PM Eastern
Extended Trading
$7.72 -0.01 (-0.18%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pyxis Tankers, Inc. is an international maritime transportation holding company, which engages in the ownership and operation of a fleet of product tankers. It also deals with the seaborne transportation and shipping of refined petroleum products and other bulk liquids. It operates through the Tanker Vessels and Dry-bulk Vessels segments. The company was founded by Valentios Valentis on March 23, 2015 and is headquartered in Maroussi, Greece.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas